Science is advancing, but slowly.

Today’s news: a hot mic caught Putin and Xi chatting about immortality and organ transplants at Beijing’s parade (Sept 3–4, 2025). Major outlets carried the clip, fueling hype.

The facts urge caution. Partial cellular reprogramming can rejuvenate tissues in animals, yet cancer risk is the key hurdle. Recent reviews stress safety first.

Early human trials are being discussed for specific diseases, not whole-body age reversal.

At ARDD 2025, developers outlined preclinical programs and a possible early-2026 start for a partial epigenetic reprogramming therapy.

OpenAI and Retro Biosciences reported a 50× boost in reprogramming markers in the lab. It’s promising, but still early-stage.